NKTR in the 13F filings
Nektar Therapeutics · CUSIP 640268306
- Quarter end
- 30 Sep 2025
- the date the book describes
- Filed
- 17 Feb 2026
- latest of these filings; the earliest 14 Nov 2025
- Managers listing it
- 5
- at least, of 95 tracked, among listed positions
- Comparable managers
- 95
- filed both Q2 2025 and Q3 2025; 0 listed it in both
- Shares listed
- 1,324,622
- combined, among listed positions
- Reported value
- $75m
- combined, at the quarter end
Among the 95 comparable managers: 4 buyers (opened or added shares) and 1 seller (trimmed or exited), at least, among listed positions. Their net change in shares is not known from listed positions, because at least one of them lists it in only one of the two quarters.
Managers listing NKTR in Q3 2025
5 of 5 holders
| Action | Filing | |||||
|---|---|---|---|---|---|---|
| Farallon Capital Management LLC | 791,000 | $45m | 0.18% | New | new | 17 Feb 2026 (the filing on sec.gov) |
| Woodline Partners LP | 233,059 | $13m | 0.06% | Trimmed | n.a. | 14 Nov 2025 (the filing on sec.gov) |
| Two Sigma Advisers LP | 178,908 | $10m | under 0.1% | New | new | 14 Nov 2025 (the filing on sec.gov) |
| Hudson Bay Capital Management LP | 107,678 | $6.1m | under 0.1% | New | new | 15 Dec 2025 (the filing on sec.gov) |
| Caxton Associates LLP | 13,977 | $795k | under 0.1% | New | new | 17 Nov 2025 (the filing on sec.gov) |
Largest increases and reductions, by shares
Increases
- Farallon Capital Management LLCnew position · 791,000 shares now+791,000
- Two Sigma Advisers LPnew position · 178,908 shares now+178,908
- Hudson Bay Capital Management LPnew position · 107,678 shares now+107,678
- Caxton Associates LLPnew position · 13,977 shares now+13,977
Reductions
No reduction among listed positions.
New positions and exits
New (4)
Exited (0)
No exit shown by a manager’s own filing.
Ownership over time
Tracked managers listing it, at least.
| Quarter | Holders | Reported value | Buyers | Sellers |
|---|---|---|---|---|
| Q2 2025 | 1 | $11m | 1 | 0 |
| Q3 2025 | 5 | $75m | 4 | 1 |
| Q4 2025 | 1 | $13m | 12 | 15 |
| Q1 2026 | 5 | $102m | 18 | 10 |
| Q2 2026 | 3 | $119m | 13 | 17 |
Compare with…
Holders over time, buyers and sellers, and the managers holding both, side by side for up to four stocks.
NKTR and LLY →NKTR and JNJ →NKTR and VRTX →Choose a stock to compare with NKTR →
How much of the picture this is
A 13F is a manager’s long US-listed equity book at a quarter end, filed up to 45 days later. It shows no shorts, cash, bonds or performance, and it is never today’s portfolio. Large books are listed to their largest positions, so a manager missing from this table may still hold a small position below that line. These are 95 tracked managers, not the institutional market.
Which funds own NKTR, latest filings →Back to the 13F Explorer →